Moxetumomab
Moxetumomab is an anti-CD22 human IgG1 κ monoclonal antibody. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control[2].
Product Specifications
CAS Number
1622075-65-3
UNSPSC
12352203
Target
ADC Antibody; CD22
Type
Inhibitory Antibodies
Related Pathways
Antibody-drug Conjugate/ADC Related; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/moxetumomab.html
Purity
99.77
Solubility
H2O
Smiles
[Moxetumomab]
Molecular Weight
(146.14 kDa)
References & Citations
[1]Robert J Kreitman, et al. Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL) : long-term follow-up from the pivotal trial. J Hematol Oncol. 2021 Feb 24;14 (1) :35.|[2]Sohita Dhillon. Moxetumomab Pasudotox: First Global Approval. Drugs. 2018 Nov;78 (16) :1763-1767.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Rabbit Polyclonal KLHL34 Antibody [FITC]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
